SUBSCRIBE
SUBSCRIBE

Sound Pharmaceuticals

IN THE PRESS
Business
Sound Pharmaceuticals, Inc. And DoD Collaborate On New Hearing Loss Guidance
September 7, 2016
 · 
2 min read
BioForest
Sound Pharmaceuticals, Inc. To Present At The 15th Annual Needham & Company Healthcare Conference
April 4, 2016
 · 
1 min read
Business
Sound Pharmaceuticals, Inc. Announces Appointment Of Paul Rickey As Chief Financial Officer
March 16, 2016
 · 
2 min read
Business
Sound Pharmaceuticals, Inc. And University of Oxford Collaborate On A New Treatment For Bipolar Disorder
March 9, 2016
 · 
2 min read
Drug Development
FDA Allows Sound Pharmaceuticals, Inc. To Begin Meniere’s Disease Clinical Trial
January 5, 2016
 · 
1 min read
Drug Development
Sound Pharmaceuticals, Inc. Submits Positive Phase 2 Clinical Trial Data On SPI-1005 For The Prevention And Treatment Of Sensorineural Hearing Loss
February 18, 2014
 · 
2 min read
Drug Development
Sound Pharmaceuticals, Inc. Successfully Completes Its First Phase 2 Clinical Trial With SPI-1005 Involving iPod® or Noise Induced Hearing Loss
November 5, 2013
 · 
1 min read
Drug Development
Sound Pharmaceuticals, Inc. Release: University of Florida Begins iPod® Trial With SPI-1005 to Prevent Hearing Loss
December 6, 2012
 · 
2 min read
Business
Nobel Prize Winner Bruce Beutler Joins Sound Pharmaceuticals, Inc.
November 29, 2012
 · 
1 min read
BioForest
Sound Pharmaceuticals, Inc. Announces a New SPI-1005 Clinical Trial Involving Personal Music Players
June 6, 2011
 · 
1 min read
Load More
JOBS